BAYER AG SPON ADR REP 1 NPV (BAYRY)

130.37
0.54 0.41
OTC
Prev Close 130.91
Open 130.10
Day Low/High 130.10 / 130.53
52 Wk Low/High 91.53 / 132.80
Volume 16.98K
Exchange OTC
Shares Outstanding 826.95B
Market Cap 109.16B
Div & Yield N.A. (N.A)

Latest News

Earnings Round-Up

Earnings Round-Up

A round-up of the morning's earnings report

European Stocks Slide Ahead Of ECB Meeting, U.S. Earnings Slate

European Stocks Slide Ahead Of ECB Meeting, U.S. Earnings Slate

European stocks fell for the first session in nearly a week Thursday as investors reacted to a mixed set of regional corporate earnings.

Bayer Leads DAX Gainers After Strong Pharma Sales in First Quarter

Bayer Leads DAX Gainers After Strong Pharma Sales in First Quarter

Bayer shares rose to the top of the German leaderboard after reporting better-than-excepted first quarter earnings that were boosted by leap in sales of the group's stroke prevention treatment.

Can Anything Dent the Fox News Brand?

Can Anything Dent the Fox News Brand?

Two sexual harassment scandals might devastate other brands, but not so with Fox News.

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.

Fox News May Be Preparing to Ax Bill O'Reilly

Fox News May Be Preparing to Ax Bill O'Reilly

With more than 70 advertisers leaving the show amid a generational shift in leadership, the Murdoch family may soon decide to cancel 'The O'Reilly Factor,' according to a report.

21st Century Fox Enlists Law Firm to Investigate Bill O'Reilly Sexual Harassment Claims

21st Century Fox Enlists Law Firm to Investigate Bill O'Reilly Sexual Harassment Claims

The media giant has asked the same law firm that conducted an investigation into former Fox News CEO Roger Ailes, who was ousted in July.

EU Approves ChemChina's $43 billion Acquisition of Syngenta

EU Approves ChemChina's $43 billion Acquisition of Syngenta

ChemChina and Switzerland's Syngenta win conditional approval from the European Commission for their $43 billion Wednesday.

ChemChina Gets FTC OK to Snap Up Syngenta

ChemChina Gets FTC OK to Snap Up Syngenta

ChemChina must sell its U.S. paraquat, abamectin and chlorothalonil crop protection businesses to California agrochemical company AMVAC.

European Stocks Post Solid Gains as Tensions Ease and Investors Look Across the Atlantic

European Stocks Post Solid Gains as Tensions Ease and Investors Look Across the Atlantic

The German DAX led Europe's markets higher Thursday with solid gains in airlines, autos and chemicals

Trump's Anti-Pot Stance Won't Hurt This 'Canna-Business' Stock

Trump's Anti-Pot Stance Won't Hurt This 'Canna-Business' Stock

President Trump's socially conservative administration has vowed to crack down on marijuana, but here's why pot investors shouldn't worry.

European Stocks Fall on Earnings Upsets, Politics

European Stocks Fall on Earnings Upsets, Politics

European stocks were weaker and bonds higher as unease returned to markets.

European Markets Fall as More Corporate Earnings Hit

European Markets Fall as More Corporate Earnings Hit

Corporate earnings and resurgent concerns over politics hit European benchmarks on Thursday.

Bayer Offers Further Detail on Financing Monsanto Takeover

Bayer Offers Further Detail on Financing Monsanto Takeover

Bayer isn't expecting their deal for Monsanto to be derailed by regulatory issues, despite recent delays.

Bayer's Cautious 2017 Outlook Causes Stock to Slump

Bayer's Cautious 2017 Outlook Causes Stock to Slump

Bayer shares fell after the drugmaker posted solid full-year earnings but said its crop sciences unit would see modest growth in 2017 as it completes its $66 billion Monsanto takeover.

Global Financial News: Earnings In The Spotlight

Global Financial News: Earnings In The Spotlight

A week full of financial reports continues, as Bayer and Lloyds post full-year earnings

European Stocks Extend Gains as Economic Data Continues to Impress

European Stocks Extend Gains as Economic Data Continues to Impress

European stocks tested multi-month highs Wednesday after better-than-expected business sentiment data from Germany and an upgrade to the fourth quarter pace of growth in the United Kingdom.

Bayer Shares Drop After Cautious 2017 Outlook For Crop Science Unit

Bayer Shares Drop After Cautious 2017 Outlook For Crop Science Unit

Bayer shares fell after the drugmaker posted solid full-year earnings but said its crop sciences unit would see modest growth in 2017 as it completes its $66 billion Monsanto takeover.

Week Ahead: Fed Is Expected to Toe the Party Line

Week Ahead: Fed Is Expected to Toe the Party Line

Investors will be watching a newly hawkish Federal Reserve in the coming week.

Basic Materials Basically Are a Good Place to Be

Basic Materials Basically Are a Good Place to Be

Chemical companies, lumber producers and other sectors that should benefit from capital spending look to do well going forward.

Regeneron Pharmaceuticals Could Be Ready to Rebound

Regeneron Pharmaceuticals Could Be Ready to Rebound

Regeneron has faced a lower stock price and patent wrangling. But the stock could be ready to rise again.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures and shares in London and Asia fall Thursday after Donald Trump offers few details on his policies during his first press conference since winning the U.S. election.

European Pharma Shares Hammered After Trump Press Conference Attack

European Pharma Shares Hammered After Trump Press Conference Attack

European health care and pharmaceutical company shares were hit hard Thursday after President-elect Donald Trump accused some firms of 'getting away with murder' in his Wednesday press conference.

'Stage Is Set' for M&A to Continue in 2017

'Stage Is Set' for M&A to Continue in 2017

Elizabeth Lim, Mergermarket America head research editor, expects further energy consolidation and increased media mergers in 2017.

Analysts Mixed on Health Care Stocks in the New Year

Analysts Mixed on Health Care Stocks in the New Year

While there is deep uncertainty about how politics will affect the health care sector in the new year, analysts seem excited about some opportunities in pharmaceuticals.

European Stocks Mixed, Oil Rises Higher in Holiday-Thinned Trading

European Stocks Mixed, Oil Rises Higher in Holiday-Thinned Trading

European stocks opened a holiday-thinned session with caution as U.S. dollar strength continues to drive sentiment.

European Stock Markets Rise as Investors Buy Back Risk Assets; London Leads

European Stock Markets Rise as Investors Buy Back Risk Assets; London Leads

U.K. stocks are buoyed by retail sales at a 14-year high, prompting a resurgence of consumer and real estate stocks.

European Stocks Slide as Bond Yields, U.S. Dollar Creep Higher

European Stocks Slide as Bond Yields, U.S. Dollar Creep Higher

European stocks are in the red Wednesday as government bond yields edge higher amid the global inflation trade.